Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1974 1
1975 1
1976 1
1978 1
1983 1
1995 1
1999 1
2001 2
2003 2
2004 1
2006 1
2007 3
2008 6
2009 8
2011 3
2012 6
2013 3
2014 4
2015 9
2016 9
2017 10
2018 6
2019 5
2020 9
2021 19
2022 15
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Modeling HIV multiple infection.
Guo T, Qiu Z, Kitagawa K, Iwami S, Rong L. Guo T, et al. Among authors: iwami s. J Theor Biol. 2021 Jan 21;509:110502. doi: 10.1016/j.jtbi.2020.110502. Epub 2020 Sep 28. J Theor Biol. 2021. PMID: 32998053
[Digital transformation of COVID-19 research].
Park H, Woo JH, Iwanami S, Iwami S. Park H, et al. Among authors: iwami s. Uirusu. 2022;72(1):39-46. doi: 10.2222/jsv.72.39. Uirusu. 2022. PMID: 37899228 Free article. Japanese.
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir.
Torii S, Kim KS, Koseki J, Suzuki R, Iwanami S, Fujita Y, Jeong YD, Ito J, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K, Matsuura Y, Shimamura T, Iwami S, Fukuhara T. Torii S, et al. Among authors: iwami s. PLoS Pathog. 2023 Mar 27;19(3):e1011231. doi: 10.1371/journal.ppat.1011231. eCollection 2023 Mar. PLoS Pathog. 2023. PMID: 36972312 Free PMC article.
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
Miyamoto S, Nishiyama T, Ueno A, Park H, Kanno T, Nakamura N, Ozono S, Aihara K, Takahashi K, Tsuchihashi Y, Ishikane M, Arashiro T, Saito S, Ainai A, Hirata Y, Iida S, Katano H, Tobiume M, Tokunaga K, Fujimoto T, Suzuki M, Nagashima M, Nakagawa H, Narita M, Kato Y, Igari H, Fujita K, Kato T, Hiyama K, Shindou K, Adachi T, Fukushima K, Nakamura-Uchiyama F, Hase R, Yoshimura Y, Yamato M, Nozaki Y, Ohmagari N, Suzuki M, Saito T, Iwami S, Suzuki T. Miyamoto S, et al. Among authors: iwami s. Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2314808120. doi: 10.1073/pnas.2314808120. Epub 2023 Dec 22. Proc Natl Acad Sci U S A. 2023. PMID: 38134196 Free PMC article.
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments.
Akazawa D, Ohashi H, Hishiki T, Morita T, Iwanami S, Kim KS, Jeong YD, Park ES, Kataoka M, Shionoya K, Mifune J, Tsuchimoto K, Ojima S, Azam AH, Nakajima S, Park H, Yoshikawa T, Shimojima M, Kiga K, Iwami S, Maeda K, Suzuki T, Ebihara H, Takahashi Y, Watashi K. Akazawa D, et al. Among authors: iwami s. J Infect Dis. 2023 Aug 31;228(5):591-603. doi: 10.1093/infdis/jiad058. J Infect Dis. 2023. PMID: 36892247 Free PMC article.
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.
Miyazaki T, Hosogaya N, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Ozawa Y, Shiko Y, Inaba Y, Kurokawa T, Hanaoka H, Iwanami S, Kim K, Iwami S, Watashi K, Miyazawa K, Umeyama T, Yamagoe S, Miyazaki Y, Wakita T, Sumiyoshi M, Hirayama T, Izumikawa K, Yanagihara K, Mukae H, Kawasuji H, Yamamoto Y, Tarumoto N, Ishii H, Ohno H, Yatera K, Kakeya H, Kichikawa Y, Kato Y, Matsumoto T, Saito M, Yotsuyanagi H, Kohno S. Miyazaki T, et al. Among authors: iwami s. Microbiol Spectr. 2023 Jun 15;11(3):e0431122. doi: 10.1128/spectrum.04311-22. Epub 2023 May 4. Microbiol Spectr. 2023. PMID: 37140398 Free PMC article. Clinical Trial.
Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma.
Yamada A, Yasunaga JI, Liang L, Zhang W, Sunagawa J, Nakaoka S, Iwami S, Kogure Y, Ito Y, Kataoka K, Nakagawa M, Iwanaga M, Utsunomiya A, Koh KR, Watanabe T, Nosaka K, Matsuoka M. Yamada A, et al. Among authors: iwami s. Cancer Sci. 2024 Jan;115(1):310-320. doi: 10.1111/cas.15997. Epub 2023 Nov 10. Cancer Sci. 2024. PMID: 37950425 Free PMC article.
Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection.
Kumata R, Iwanami S, Mar KB, Kakizoe Y, Misawa N, Nakaoka S, Koyanagi Y, Perelson AS, Schoggins JW, Iwami S, Sato K. Kumata R, et al. Among authors: iwami s. PLoS Comput Biol. 2022 Apr 25;18(4):e1010053. doi: 10.1371/journal.pcbi.1010053. eCollection 2022 Apr. PLoS Comput Biol. 2022. PMID: 35468127 Free PMC article.
131 results